ASLN ASLAN Pharmaceuticals Limited ADRs

ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$2.73  -0.18 (-6.19%)
As of 03/27/2023 11:20:05 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Singapore
Country of incorporation:  
IPO date:  05/04/2018
Outstanding shares:  7,598,200
Average volume:  89,035
Market cap:   $20,895,050
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%